Skip to content

Reserch Non-Helicobacter pylori Helicobacter infection

Reserch of lesion extinction effect by H.suis eradication for gastric MALT lymphoma and intractable peptic ulcer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs031200105
Enrollment
50
Registered
2020-09-02
Start date
2020-10-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric MALT lymphoma, intractable peptic ulcer NHPH infection, gastric MALT, refractory peptic ulcer.

Interventions

In case of confirmed H. suis infection, deworming agent is administered
H.suis sterilization

Sponsors

Suzuki Hidekazu
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with H.pylori negative gastric MALT lymphoma who are able to observe the lesion endoscopically Patients with H.pylori-negative or non-NSAIDs confirmed gastric or duodenal ulcer after eradication 1) Patients (both male and female) over the age of 18 2) Patients who have obtained written consent and their surrogates (if they are minors, consent is obtained from the surrogate) 3) Patients diagnosed with gastric MALT lymphoma or gastric or duodenal ulcer 4) Patients who are H.pylori negative or after successful H.pylori eradication treatment (5) Whether inpatient or outpatient

Exclusion criteria

Exclusion criteria: 1) Patients who could not give consent 2) Patients with poorly controlled complications Patients with advanced stages of cancer Patients with acute or unstable underlying disease 3) Pregnant or lactating women 4) Patients taking drugs with a high rate of drug interactions expected to occur during treatment

Design outcomes

Primary

MeasureTime frame
Success or failure of NHPH include H.suis sterilization and the efficacy of eradication of disease

Secondary

MeasureTime frame
Identify the most recommended method of H.suis sterilization Verification of which H.suis infection diagnostics are useful in determining the success of eradication 1. gastric MALT lymphoma patients and gastric/duodenal ulcer patients after H.pylori-negative or H.pylori eradication treatment NHPH infection rate including H.suis 2. incidence of adverse events due to NHPH eradication, including H.suis 3. evaluation of drugs for the treatment of NHPH infection, including H.suis 4. evaluation of diagnostic methods for NHPH infection, including H.suis

Contacts

Public ContactMasaya Sano

Tokai University School of Medicine

m-sano@tokai.ac.jp+81-463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026